Topics:

Deputy Director Named for FDA’s Division of Oncology Drug Products

Deputy Director Named for FDA’s Division of Oncology Drug Products

Grant Williams, MD, recently assumed the position of deputy director of the Division of Oncology Drug Products, Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA). Dr. Williams joined the FDA in 1989 as a medical officer and was named oncology medical team leader in 1996. Prior to joining the FDA, Dr. Williams completed an internship and residency in internal medicine and a fellowship in hematology/oncology at the University of Alabama at Birmingham. He earned his medical degree from the University of Alabama in 1982.

Exemplary Leadership

During his tenure at the FDA, Dr. Williams has served as the primary reviewer for more than 15 new drug applications (NDAs)/efficacy supplements and as medical team leader for more than 20 NDAs, including the imatinib mesylate (Gleevec) NDA that was completed in 2½ months. He organized a 17-course lecture series for new oncology reviewers and has chaired the CDER’s Oncology Coordinating Committee since its inception in 2001.

Dr. Williams’ numerous other FDA-related activities have included writing the Center for Biologics, Evaluation, and Research (CBER)-CDER Oncology Guidances, organizing oncology advisory committee meetings, and speaking to both professional and patient advocacy groups.

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.